{"id":22374,"date":"2015-10-22T11:50:29","date_gmt":"2015-10-22T09:50:29","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?page_id=22374"},"modified":"2024-10-16T19:33:29","modified_gmt":"2024-10-16T17:33:29","slug":"centro-documentazione","status":"publish","type":"page","link":"https:\/\/www.fedaiisf.it\/en\/centro-documentazione\/","title":{"rendered":"Documentation Center"},"content":{"rendered":"

The FEDAIISF Study and Research Documentation Center is an instrumental body of FEDAIISF, it has managerial autonomy on the production of documents relating to the world of scientific information on drugs and parapharmaceuticals and the various problems connected to it. In carrying out its duties, it pursues aims aimed at promoting and safeguarding the values and transparency of scientific information policies.<\/strong><\/span><\/p>\n

________________________________<\/strong><\/p>\n

\u00a0Il ruolo associativo sulla normativa dell’informazione scientifica del farmaco<\/span><\/span><\/span><\/a><\/strong><\/span><\/p>\n

Relazione al XXXVI Congresso Internazionale della Societ\u00e0 Farmaceutica del Mediterraneo Latino – <\/strong><\/span>PharmEvolution – Catania 11 ottobre 2024<\/strong><\/span><\/p>\n

Richard Bevilacqua<\/strong><\/span><\/p>\n

\"\"<\/a><\/p>\n

The birth of scientific drug information: from its origins to the present day. Semi-serious story<\/a><\/strong><\/span><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/p>\n

 <\/p>\n

Types of Vacini in studies<\/span>oo already on the market against SARS-Cov-<\/a><\/span>2
\n<\/span><\/span><\/strong>Dr. Anna Passoni<\/span>
\n<\/strong><\/span><\/span>January 10, 2021\"\"<\/a><\/mark><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/p>\n

The future model of the report <\/a>
\n<\/span><\/strong><\/span>Pharma-MMG<\/span><\/a>
\n<\/span><\/strong><\/span>dr. Richard Bevilacqua<\/span>
\n<\/span><\/strong><\/span><\/span>October 20, 2020<\/span><\/p>\n

\"\"<\/a>We thank ADG for authorizing the publication
\ntranslation by Riccardo Bevilacqua<\/span><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/p>\n

Covid-19 and ISF dossier<\/span><\/a>
\n<\/strong><\/span>dr. Richard Bevilacqua
\n<\/span><\/span><\/span>April 14, 2020<\/strong><\/span>
\n<\/span><\/span>\"\"<\/span><\/a><\/h1>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/span><\/p>\n

COVID-19 file
\n<\/span><\/strong><\/span>Dr. Anna Passoni<\/span>
\n<\/span><\/strong>last updated \u2013 May 7, 2020<\/span>\"\"<\/a>COVID-19 file \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 21\/03\/2020<\/span><\/span>
\n<\/span>COVID-19 file Update\u00a0 <\/span>#1<\/span> \u00a0 30\/03\/2020
\n<\/span><\/span>COVID-19 file Update\u00a0 <\/span>no.2 <\/span>\u00a0 03\/04\/2020<\/span><\/a>
\n<\/span>COVID-19 file Update<\/span> n.3 13\/04\/2020<\/span><\/a><\/span><\/p>\n

\u00a0\u00a0\u00a0\u00a0\u00a0 COVID-19 Dossier Index n.3<\/span><\/a><\/span> 13\/04\/2020<\/span><\/a><\/span><\/p>\n

ATTACHMENTS:<\/span><\/p>\n

Attachment 1: ACE2 COVID-19 treatment <\/strong><\/a>
\n<\/span><\/span>30\/03\/2019<\/a>
\n<\/span>Annex 2: COVID Treatment Guidelines<\/strong><\/a>
\n<\/span><\/span>19\/03\/2020<\/a>
\n<\/span>Annex 3: ISPI analysis <\/strong><\/a>
\n<\/span><\/span>27\/03\/2020<\/a>
\n<\/span>Attachment: 4 TOCIVID-19-Synopsis <\/strong><\/a>
\n<\/span><\/span>18\/03\/2020<\/a>
\n<\/span>Attachment 5: Update \u2013 Spallanzani prot adult patient<\/strong><\/a>
\n<\/span><\/span>17\/03\/2020<\/a>
\n<\/span>Annex 6: Spallanzani experimental drugs Nicastri<\/strong><\/a>
\n<\/span><\/span>2020
\n<\/span>Attachment 7: update \u2013 Report-COVID-2019<\/strong> <\/a>
\n<\/span><\/span>09\/04\/2020 <\/a>
\n<\/span>Annex 8: Report-COVID-2019 <\/strong><\/a>
\n<\/span><\/span>09\/04\/2020<\/a>
\n<\/span>Annex 9: pediatric acroischemia case report<\/strong><\/a>
\n2020
\n<\/span><\/span><\/p>\n